MedTrace Logo

Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

NCT04852406 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 526

Last updated 2025-07-31

No results posted yet for this study

Summary

The purpose of this pragmatic interventional study is to evaluate whether a protocol-based management of antithrombotic drugs can reduce a composite of perioperative outcomes in patients with chronic antithrombotic therapy before surgery.

Conditions

  • Antithrombotic Therapy
  • Perioperative Care
  • Perioperative Outcomes

Interventions

DRUG

Protocol-based management of perioperative antithrombotic therapy

Perioperative antithrombotic therapy is managed according to the latest expert consensus published in the Chinese Medical Journal, 2020.

DRUG

Routine management of perioperative antithrombotic therapy

Perioperative antithrombotic therapy is managed according to current routine practice.

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Hong Zhang · Peking University First Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-21
Primary Completion
2025-12-31
Completion
2026-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04852406 on ClinicalTrials.gov